Viacl

Vical's Allovectin Phase 3 Trial Results: Consider The Possibilities
Seeking Alpha
Tue, 07/9/13 - 07:45 am
Viacl
Allovectin
Merck
Roche
Amgen
Bristol-Myers Squibb